Form 4: 89bio Executive Le-Nguyen Quoc Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Quoc Le-Nguyen, Chief Technical Operations Officer of 89bio, Inc., reports acquisition of stock options and restricted stock units, as well as disposition of shares to cover tax obligations.

Summary

  • On February 1, 2025, Quoc Le-Nguyen, Chief Technical Operations Officer of 89bio, Inc., acquired 80,000 shares of common stock and disposed of 3,338 shares to cover tax obligations.
  • The acquisition of 80,000 shares was in the form of restricted stock units.
  • Le-Nguyen also acquired a right to purchase 320,000 shares of 89bio's common stock in the form of stock options.
  • Following these transactions, Le-Nguyen directly owns 348,495 shares of 89bio, Inc.
  • The stock options have an exercise price of $9.60.
  • The price of the disposed shares was $9.60.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The acquisition of stock options and restricted stock units is a positive sign, but the sale of shares to cover taxes is a minor negative.

Positives

  • The acquisition of restricted stock units and stock options indicates confidence in the company's future performance.

Negatives

  • The disposition of shares to cover tax obligations slightly reduces Le-Nguyen's holdings.

Risks

  • The vesting of restricted stock units and stock options is contingent upon continued service to the Issuer, creating a potential risk if Le-Nguyen leaves the company.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules of the restricted stock units and stock options suggest a multi-year commitment from the executive.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Stakeholder Impact

  • The transactions may have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.

Key Dates

DateDescription
02/01/2025Date of stock acquisition and disposition, and grant of stock options.
02/01/2026First vesting date for a quarter of the stock options.
02/01/2035Expiration date of the stock options.
02/04/2025Date of Form 4 filing.

Keywords

89bio, ETNB, Form 4, insider trading, stock options, restricted stock units, Quoc Le-Nguyen, Chief Technical Operations Officer, stock acquisition, stock disposition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.